Chryseobacterium meningosepticum sepsis complicated with retroperitoneal hematoma and pleural effusion in a diabetic patient

Journal of the Chinese Medical Association

Volumn 71, Issue 9, 2008, Pages 473-476

  Lee, Shou Wu ^a   Tsai, Che An ^a   Lee, Bor Jen ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Chryseobacterium meningosepticum; Pleural effusion; Retroperitoneal hematoma

Indexed keywords

COTRIMOXAZOLE; LEVOFLOXACIN; MINOCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ABSCESS DRAINAGE; ADULT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CHRYSEOBACTERIUM MENINGOSEPTICUM; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DIABETIC PATIENT; FEVER; GRAM NEGATIVE SEPSIS; HOSPITALIZATION; HUMAN; MALE; PATIENT TRANSPORT; PLEURA EFFUSION; RESPIRATORY CARE; RETROPERITONEAL ABSCESS; RETROPERITONEAL HEMATOMA; TREATMENT OUTCOME;

EID: 54549113130     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70151-5     Document Type: Article

References (16)

1. Steinberg JP, Del Rio C. Principles and Practice of Infectious Disease, 5th edition. Edinburgh: Churchill Livingstone, 2000: 2459-74.
2. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Color Atlas and Textbook of Diagnostic Microbiology, 4th edition. Philadelphia: JB Lippincott, 1992:185-242.
3. Thong ML, Puthucheary SD, Jee EL. Flavobacterium meningosepticum infection: an epidemiologic study in a newborn nursery. J Clin Pathol 1981;34:429-33.
4. Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Medicine 1997;76:30-41.
5. Teres D. ICU-acquired pneumonia due to Flavobacterium meningosepticum. JAMA 1974;228:732.
6. Werthamer S, Weiner M. Subacute bacterial endocarditis due to Flavobacterium meningosepticum. Am J Clin Pathol 1971; 57:410-2.
7. Gardner P, Griffin WB, Achwartz MN, Kuntz LJ. Nonfermentative Gram-negative bacilli of nosocomial interest. Am J Med 1970;48:735-49.
8. Abrahamsen TG, Finne PH, Lingaas E. Flavobacterium meningosepticum infection in a neonatal intensive care unit. Acta Paediatr Scand 1989;78:51-5.
9. Pokrywka M, Viazanko K, Medvick J, Knabes S, Pasculle AW, Dowling JN. A Flavobacterium meningosepticum outbreak among intensive care patients. Am J Infect Control 1993;21:139-45.
10. Marnejon T, Watanakunkom C. Flavobacterium meningosepticum septicemia and peritonitis-complicated CAPD. Clin Nephrol 1992;38:176-7.
11. Korzets Z, Maayan MC, Bernheim J. Flavobacterial peritonitis in patients treated by peritoneal dialysis. Nephrol Dial Transplant 1995;10:280-3.
12. Sheridan RL, Ryan CM, Pasternack MS, Weber JM, Tompkins RG. Flavobacterial sepsis in massively burned pediatric patients. Clin Infect Dis 1993;17:185-7.
13. Wu V Tsai TJ, Wang R, Hsueh RR. Peritonitis caused by Chryseobacterium meningosepticum in a patient undergoing continuous ambulatory peritoneal dialysis. J Formos Med Assoc 2003;102:270-3.
14. Di Pentima MC, Mason EO Jr, Kaplan SL. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options. Clin Infect Dis 1998;26:1169-76.
15. Tizer KB, Cervia JS, Dunn AM, Stavola JJ. Successful combination vancomycin and rifampin therapy in a newborn with community-acquired C. meningosepticum neonatal meningitis. Pediatr Infect Dis 1995;14:915-7.
16. Lin PY, Chu C, Su LH, Huang CT, Chang WY, Chin CH. Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in nonneonatal patients. J Clin Microbiol 2004;42:3353-5.